OTCPicks.com’s Daily Small Cap and Microcap Newsletter presents a range of the hottest small cap stocks on trading on the OTC and OTCBB markets. In addition to our Newsletters, OTCPicks.com is quickly becoming the premier community destination for small cap and microcap traders to meet up and discuss their top stock picks. Visit http://www.otcpicks.com/microcap.htm today to join this growing community.
Our Stocks to Watch today include Perf Go Green Holdings Inc. (OTCBB: PGOG), ICO Global Communications (Holdings) Ltd. (Nasdaq: ICOG), Advaxis Inc. (OTCBB: ADXS) and Intellect Neurosciences Inc. (OTCBB: ILNS).
For the complete newsletter please visit: http://www.otcpicks.com/daily-market-movers/index.php
For more in-depth coverage of small cap stocks visit http://www.otcpicks.com/microcap.htm
PERF GO GREEN HOLDINGS INCORPORATED (OTCBB: PGOG)
Company Profile: http://www.otcpicks.com/perf-go-green/perf-go-green.htm
Perf Go Green Holdings, Inc. is engaged in the creation and global marketing of 100% eco-friendly, non-toxic, food-contact-compliant, biodegradable plastic products. All Perf Go Green products are made from recycled plastics and completely break down in landfill within two years, leaving no toxic or visible residue, as compared to other plastics that take hundreds of years. Perf Go Green’s corporate name reflects its "Go Green" mission to develop, market and distribute biodegradable plastic products as a practical and viable solution to eliminating plastic waste from the world environment.
ICO GLOBAL COMMUNICATIONS LIMITED (NASDAQ: ICOG)
"Up 27.27% in morning trading"
ICO Global Communications (Holdings) Limited, a development stage company, provides mobile satellite services (MSS) using geosynchronous earth orbit satellite in the United States and internationally. It operates a medium earth orbit satellite system in the 2 GHz band that provides data gathering services. The company also develops a hybrid MSS/ATC System with satellite and terrestrial communications capabilities. Its MSS/ATC System allows providing wireless voice, video, data, and Internet service on mobile and portable devices. The company was founded in 1995 and is based in Reston, Virginia.
ADVAXIS INCORPORATED (OTCBB: ADXS)
"Up 25.00% in morning trading"
Based in North Brunswick, New Jersey, Advaxis is developing proprietary Listeria monocytogenes ("Lm") cancer vaccines based on technology developed by Dr. Yvonne Paterson, Professor of Microbiology at the University of Pennsylvania and Chairperson of Advaxis’ Scientific Advisory Board. Advaxis is developing attenuated live Listeria-based vaccines that deliver engineered tumor antigens, which safely stimulate multiple simultaneous immunological mechanisms to fight cancer. Advaxis’ lead Listeria vaccine candidate, Lovaxin-C, targets human papilloma virus ("HPV")-associated cancers such as cervical and head and neck. Current Lm vaccines in development target prostate, breast, ovarian and other cancers. Recently, Advaxis completed a Phase I clinical trial of Lovaxin-C. A Phase II clinical trial is planned for patients with cervical intraepithelial neoplasia ("CIN"). The Lm platform also has applications in the fields of infectious disease and autoimmune disorders.
INTELLECT NEUROSCIENCES (OTCBB: ILNS)
"Up 11.76% in morning trading"
Intellect Neurosciences, Inc., a biopharmaceutical company, engages in the discovery and development of disease-modifying therapeutic agents for the treatment and prevention of Alzheimer's disease and other disorders of the central nervous system. The company's product pipeline includes small molecules, monoclonal antibodies, and vaccines that address unmet needs in Alzheimer's disease and other indications, including ataxia, Parkinson's disease, Huntington's disease, diabetes, stroke, myelodysplastic syndromes, motor neuron disease (ALS and Lou Gehrig's disease), and radiation injury. Its lead drug candidate, OXIGON, is a chemically synthesized form of a small, potent, dual mode of action, naturally occurring molecule with potential as a disease-modifying agent for Alzheimer's disease and other therapeutic indications. OXIGON has completed human Phase Ia clinical trials. Intellect Neurosciences also develops immunotherapies (monoclonal antibodies and vaccines) to prevent or arrest the progression of Alzheimer's disease, while avoiding the risk of adverse reactions. The company also has various proprietary immunotherapy platforms, such as ANTISENILIN, RECALL-VAX, and BETA-VAX with patented drug candidates for both passive and active immunization against Alzheimer's disease. ANTISENILIN is a passive monoclonal antibody platform, and RECALL-VAX and BETA-VAX are platform technologies for vaccination. The company was founded in 2005 and is headquartered in New York, New York.
About OTCPicks.com
OTCPicks.com is fast becoming the premier Internet destination for investors seeking information on smallcap and microcap companies. The web site features companies in Profile Campaigns, Executive Interviews and Research Reports authored by our financial writers. We publish our Daily Market Movers Digest Newsletter to opt-in investor members. OTCPicks.com presents the latest information for the discerning small cap and microcap investor. The site features informative articles on microcap investing, the top penny stock picks, and a wealth of small cap research on vertical markets. To feature a company on OTCPicks.com, please contact our publisher, Brian Dean at 972-546-3740, or via email at publisher@otcpicks.com.
Forward-Looking Statement: This press release includes "forward-looking statements" within the meaning of the federal securities laws, commonly identified by such terms as "believes," "looking ahead," "anticipates," "estimates" and other terms with similar meaning. Although the Company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Important factors that could cause actual results to differ materially from the Company's projections and expectations are disclosed in the Company's filings with the Securities and Exchange Commission. All forward-looking statements in this press release are expressly qualified by such cautionary statements and by reference to the underlying assumptions.
Disclosure: OTCPicks.com has been compensated eight thousand dollars by a third party (BlueWave Advisors) for PGOG advertising and promotional services.
OTCPicks.com is not a registered investment advisers or broker/dealer. OTCPicks.com makes no recommendation that the purchase of securities of companies profiled in this website is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk.
